(lp0
S"Insys: Syndros Missteps And Even More Subsys Arrests Seeking Alpha - Mar 27, 2017 ... on Insys Therapeutics . Insys' THC drug Syndros finally received DEA scheduling as a Schedule II drug  which may limit the company's available market share for the drug. At the ...Insys Therapeutics Moves Ahead With Synthetic THC - Green Rush DailyDEA Reschedules Insys Therapeutics' Pharmaceutical Cannabinoid Medication - Cannabis Business Times"
p1
aS"Insys Announces Saeed Motahari to Become President and Chief Executive Officer ... GlobeNewswire  - Mar 27, 2017 PHOENIX, March 27, 2017  -- Insys Therapeutics, Inc.   today announced that, effective April 17, 2017, Saeed Motahari, will become the Company's President and Chief Executive Officer &nbsp;...Insys Therapeutics Inc  Given a $16.00 Price Target at Royal Bank of Canada - The Cerbat GemInsys Therapeutics Inc  Upgraded to Hold at Zacks Investment Research - Chaffey Breeze"
p2
aS'INSY SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of ... Yahoo Finance - 10 hours ago NEW YORK, March 28, 2017  -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased&nbsp;...'
p3
aS'Biotech Quick Pick: Insys Therapeutics Seeking Alpha - Mar 13, 2017 To determine if Insys Therapeutics is a long or short opportunity we will first translate the current stock price into a series of assumptions the market seems to be making about the future of the company. As evidenced by a 98% decline from highs ...Insys Therapeutics Inc  Set to Announce Earnings on Thursday - Chaffey BreezeRecent Update on Price Movements: Insys Therapeutics, Inc.  - Is stories'
p4
aS'Insys Therapeutics Inc. to invest $24 million in Round Rock facility Community Impact Newspaper - Mar 23, 2017 On Thursday, Insys Therapeutics Inc. announced an expansion of its Round Rock location with an additional $24 million investment.Pharmaceutical Company Expands Round Rock Facility - Patch.com'
p5
aS'Insys Therapeutics, Inc.  Files An 8-K Departure of Directors or ... Market Exclusive - Mar 27, 2017 The Company markets Subsys through its field sales force focused on supportive care physicians in the United States. Subsys delivers a liquid fentanyl formulation in approximately 100, 200, 400, 600, 800, 1,200 and 1,600 micrograms  dosages.'
p6
aS'INSY NOTICE: Rosen Law Firm Reminds Insys Therapeutics, Inc. Investors of ... Yahoo Finance - Mar 24, 2017 Rosen Law Firm, a global investor rights law firm, reminds purchasers of Insys Therapeutics, Inc. securities  from February 23, 2016 through March 15, 2017, inclusive  of the important May 16, 2017 lead plaintiff deadline in ...'
p7
aS'Robbins Arroyo LLP: Insys Therapeutics, Inc.  Misled Shareholders ... Yahoo Finance - Mar 23, 2017 Shareholder rights law firm Robbins Arroyo LLP announces that a class action complaint was filed against Insys Therapeutics, Inc.  in the U.S. District Court for the Southern District of New York. The complaint is brought on behalf of all ...'
p8
aS'Insys Therapeutics Announces Delay in the Release of its Fourth Quarter and ... GlobeNewswire  - Mar 15, 2017 PHOENIX, March 15, 2017  -- Insys Therapeutics, Inc.   today announced that the Company will delay the release of its financial results for the fourth quarter and full year 2016.INSYS Therapeutics, Inc.  investors have generally bought the stock ... - Post AnalystLatest Stocks: The Insys Therapeutics Inc  to Release Quarterly Earnings ... - Petro Global News 24'
p9
aS'Traders Secrets on INSYS Therapeutics, Inc. , Merit Medical Systems, Inc ... StockNewsJournal - Mar 27, 2017 ROI deals with the invested cash in the company and the return the investor realize on that money based on the net profit of the business.'
p10
a.